Similar to our research, Choi et al. (Choi et al., 2020) built a group of five DEG markers, namely, BCL2, HER2, CD133, CAIX and ERCC1, which can be used to predict the response to chemotherapy and prognosis of cervical cancer. This evidence concerns the gene ERBB2 and cervical cancer.